Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Baxter
Johnson and Johnson
Mallinckrodt
Boehringer Ingelheim

Last Updated: January 16, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Pyridoxamine


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Pyridoxamine?

Pyridoxamine is an investigational drug.

There have been 7 clinical trials for Pyridoxamine. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2014.

The most common disease conditions in clinical trials are Diabetic Nephropathies, Kidney Diseases, and Diabetes Mellitus, Type 2. The leading clinical trial sponsors are Collaborative Study Group (CSG), Medpace, Inc., and NephroGenex, Inc.

There is one US patent protecting this investigational drug and eleven international patents.

Recent Clinical Trials for Pyridoxamine
TitleSponsorPhase
Methylglyoxal (MGO) Lowering Cocktail to Reduce Appetite in Obese IndividualsUniversity of California, San FranciscoPhase 1/Phase 2
Advanced Glycation Endproducts and Bone Material Strength in T2D Treated With PyridoxamineColumbia UniversityN/A
Pyridorin in Diabetic NephropathyCollaborative Study Group (CSG)Phase 3

See all Pyridoxamine clinical trials

Clinical Trial Summary for Pyridoxamine

Top disease conditions for Pyridoxamine
Top clinical trial sponsors for Pyridoxamine

See all Pyridoxamine clinical trials

US Patents for Pyridoxamine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Pyridoxamine ⤷  Sign up for a Free Trial Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the sn-2 position COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (Acton, AU) GRAINS RESEARCH AND DEVELOPMENT CORPORATION (Barton, AU) NUSEED PTY LTD. (Laverton North, AU) ⤷  Sign up for a Free Trial
Pyridoxamine ⤷  Sign up for a Free Trial Compounds useful for the treatment of metabolic disorders and synthesis of the same North Carolina Central University (Durham, NC) The University of North Carolina at Chapel Hill (Chapel Hill, NC) ⤷  Sign up for a Free Trial
Pyridoxamine ⤷  Sign up for a Free Trial Particle detecting device AZBIL CORPORATION (Chiyoda-ku, JP) ⤷  Sign up for a Free Trial
Pyridoxamine ⤷  Sign up for a Free Trial Compositions and methods useful for ameliorating age related maladies NestecSA (Vevey, CH) ⤷  Sign up for a Free Trial
Pyridoxamine ⤷  Sign up for a Free Trial Nutritional composition for promoting gut microbiota balance and health Nestec S.A. (Vevey, CH) ⤷  Sign up for a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Pyridoxamine

Drugname Country Document Number Estimated Expiration Related US Patent
Pyridoxamine Argentina AR098831 2033-12-18 ⤷  Sign up for a Free Trial
Pyridoxamine Australia AU2014366839 2033-12-18 ⤷  Sign up for a Free Trial
Pyridoxamine Australia AU2015281791 2033-12-18 ⤷  Sign up for a Free Trial
Pyridoxamine Australia AU2020203743 2033-12-18 ⤷  Sign up for a Free Trial
Pyridoxamine Brazil BR112016014508 2033-12-18 ⤷  Sign up for a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Baxter
Johnson and Johnson
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.